Concepedia

Melinda M. Rottas

MM

3

Publications

148

Citations

3

H-Index

2009

Active since

Affiliations

Pfizer (United States)(Current)

Melinda M. Rottas is an author at Pfizer (United States) specializing in clinical trials, racial disparities, and population.

Top concepts

Publications per year

2009–2023

3

Publications

3

Discovery of 4-(5-Methyloxazolo[4,5-<i>b</i>]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a Novel α7 Nicotinic Acetylcholine Receptor Agonist for the Treatment of Cognitive Disorders in Schizophrenia: Synthesis, SAR Development, and in Vivo Efficacy in Cognition Models

Christopher J. O’Donnell, Bruce N. Rogers, Brian S. Bronk et al. · Journal of Medicinal Chemistry · 2009 · 73 citations · Full text

Demographic diversity of participants in Pfizer sponsored clinical trials in the United States

Melinda M. Rottas, Peter F. Thadeio, Rachel N. Simons et al. · Contemporary Clinical Trials · 2021 · 50 citations · Full text

, , +21

A framework for setting enrollment goals to ensure participant diversity in sponsored clinical trials in the United States

Mark R. Cullen, Adina R. Lemeshow, Sandra Cristina Ferreira Amaro et al. · Contemporary Clinical Trials · 2023 · 25 citations · Full text

Rows per page

1–3 of 3